BEACON-LUNG Study
Study to identify patients who may benefit from a triplet treatment regimen
ENIGMA Study
Study biological specimens from patients with ALK+ NSCLC
EoYLC Study
Study risk factors for lung cancer in persons under age 50
SPACEWALK Study
Study outcomes of patients with ALK+ TKI Drug Resistance
SPARK Study
Study new mutations after treatment in KRAS lung cancer
